Literature DB >> 30100111

Robotic versus open partial nephrectomy for highly complex renal masses: Comparison of perioperative, functional, and oncological outcomes.

Juan Garisto1, Riccardo Bertolo1, Julien Dagenais1, Daniel Sagalovich1, Khaled Fareed1, Amr Fergany1, Robert Stein1, Jihad Kaouk2.   

Abstract

INTRODUCTION: We aimed to compare perioperative, functional and oncological outcomes between robot-assisted partial nephrectomy (RAPN) and open partial nephrectomy (OPN) for highly complex renal tumors (R.E.N.A.L. nephrometry Score > 9).
METHODS: A retrospective review of 1,497 patients who consecutively underwent partial nephrectomy at a single academic tertiary center between 2008 and 2016 was performed to get data about patients who underwent RAPN and OPN for renal masses with RENAL score > 9. Baseline, perioperative, functional, and oncological outcomes were compared.
RESULTS: Two hundred and three RAPN and 76 OPN were extracted. Patients' demographics and tumors' characteristics were comparable between the groups. Blood loss (200 vs. 300 cc, P < 0.0001), intraoperative transfusion rates (3% vs. 15.8%, P < 0.001), and length of stay (3 vs. 5 days, P < 0.01) were lower for RAPN. A significant decrease in estimated glomerular filtration rate was observed from preoperative to postoperative period, regardless the approach (OPN, P = 0.026 vs. RAPN, P = 0.014). Conversion to radical nephrectomy was 7.8% and 5.9% for OPN and RAPN, respectively. At multivariable regression, open approach was predictive of intraoperative transfusion and reoperation. Overall actuarial rate of recurrence or metastasis was 4.3%, with 3 cancer-related deaths occurring after a median follow-up of 25 months. No differences were found between the groups.
CONCLUSION: In our large single-institutional series of patients who underwent partial nephrectomy for highly complex renal tumors, robotic approach appeared to be a valuable alternative to OPN, with the advantages of reduced blood loss, ischemia time, transfusions rate, and length of stay.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Partial nephrectomy; RENAL nephrometry score; Renal cell carcinoma; Robotics

Mesh:

Year:  2018        PMID: 30100111     DOI: 10.1016/j.urolonc.2018.06.012

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  16 in total

1.  The limits of complex partial nephrectomy: are there any?

Authors:  Vignesh T Packiam; R Houston Thompson
Journal:  Ann Transl Med       Date:  2019-12

2.  Intracorporeal renal hypothermia with ice slush for robot-assisted partial nephrectomy in a highly complex renal mass.

Authors:  José Luis Bauza; Prithvi Murthy; Daniel Sagalovich; Riccardo Bertolo; Enrique Pieras; Pedro Piza; Jihad Kaouk
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

3.  Positive Surgical Margins After Robot-Assisted Partial Nephrectomy Predict Long-Term Oncologic Outcomes for Clinically Localized Renal Masses.

Authors:  B Malik Wahba; Alexander K Chow; Kefu Du; Kenneth G Sands; Alethea G Paradis; Joel M Vetter; Ramakrishna Venkatesh; Eric H Kim; Sam B Bhayani; R Sherburne Figenshau
Journal:  J Endourol       Date:  2021-01-06       Impact factor: 2.619

4.  Long-term oncologic outcomes of positive surgical margins following robot-assisted partial nephrectomy.

Authors:  Michael B Rothberg; Taylor C Peak; Christopher R Reynolds; Ashok K Hemal
Journal:  Transl Androl Urol       Date:  2020-04

5.  Comparison of robotic and open partial nephrectomy for highly complex renal tumors (RENAL nephrometry score ≥10).

Authors:  Jung Kwon Kim; Hakmin Lee; Jong Jin Oh; Sangchul Lee; Sung Kyu Hong; Sang Eun Lee; Seok-Soo Byun
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

6.  'Trifecta' outcomes of robot-assisted partial nephrectomy: Results of the 'low volume' surgeon.

Authors:  Cem Basatac; Haluk Akpinar
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

7.  Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism.

Authors:  Marieke J Krimphove; Stephen W Reese; Xi Chen; Maya Marchese; Daniel Pucheril; Eugene Cone; Wesley Chou; Karl H Tully; Adam S Kibel; Richard D Urman; Steven L Chang; Luis A Kluth; Prokar Dasgupta; Quoc Dien Trinh
Journal:  Investig Clin Urol       Date:  2020-11-13

Review 8.  Role of minimally invasive partial nephrectomy in the management of renal mass.

Authors:  Randall A Lee; David Strauss; Alexander Kutikov
Journal:  Transl Androl Urol       Date:  2020-12

Review 9.  A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Authors:  Daniel M Geynisman; Jodi K Maranchie; Mark W Ball; Gennady Bratslavsky; Eric A Singer
Journal:  Urol Oncol       Date:  2021-06-04       Impact factor: 2.954

10.  Robot-assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score-based analysis.

Authors:  Wen Deng; Junhua Li; Xiaoqiang Liu; Luyao Chen; Weipeng Liu; Xiaochen Zhou; Jingyu Zhu; Bin Fu; Gongxian Wang
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.